# Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer

> **NCT05141630** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer Female

## Interventions

- **PROCEDURE:** sentinel lymph node biopsy or targeted axillary dissection alone

## Key facts

- **NCT ID:** NCT05141630
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01-01
- **Primary completion:** 2024-01-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05141630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05141630, "Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05141630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*